Eagle Plains Announces Approval of Warrant Expiry Extension

Submitted by Anonyme on 2026-07-30T23:15:02+02:00
CRANBROOK, BC /ACCESS Newswire/ July 30, 2026 / Eagle Plains Resources Ltd. (TSXV:EPL)(OTCQB:EGPLF) ("EPL" or "Eagle Plains" or "the Company")has received approval from the TSX Venture Exchange to amend the term of 2,220,750 outstanding common share purchase warrants which were issued in connection with a non-brokered private placement completed in August, 2023, (see EPL news release datedAugust...
Anglais

Yoshihiro Shimamura Joins the Marché du Film’s “Investors Circle 2026” as an Invited Investor, Backing a New Feature Film

Submitted by Anonyme on 2026-07-17T03:15:01+02:00
Shimamura Yoshihiro Film Production Co., Ltd. (Head office: Osaka, Japan; Representative Director: Yoshihiro Shimamura), a company active in film production and investment, today announced that Representative Director Yoshihiro Shimamura has decided to invest in an international feature film after being invited to the “Investors Circle 2026” — a distinction that reflects his standing...
Anglais

Meiji Seika Pharma: Results from the Global Phase III Trial (Integral-2) of Nacubactam, a Novel β-Lactamase Inhibitor, Highlighted in The Lancet Microbe’s Coverage of ESCMID Global Congress 2026

Submitted by Anonyme on 2026-07-17T03:15:01+02:00
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that results from the global Phase III trial (Integral-2) of nacubactam (Development Code: OP0595), a novel β-lactamase inhibitor, were highlighted in The Lancet Microbe’s coverageof...
Anglais

Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies

Submitted by Anonyme on 2026-07-17T00:15:01+02:00
Takeda( TSE:4502/NYSE:TAK )announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), a next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1Presented at the 2026 American Academy of Dermatology (AAD) Innovation Academy, these secondary endpoint data show that zasocitinib demonstrated consistent and high rates of skin clearance across hard-to-treat...
Anglais

Merz Completes Inaugural €450 Million Schuldschein Loan Issuance

Submitted by Anonyme on 2026-07-17T00:15:01+02:00
The Merz Group has successfully completed its first-ever Schuldschein loan issuance, placing a total volume of €450 million in the debt capital market – a multiple of three relating to the launch volume. The debut transaction was significantly oversubscribed and attracted strong interest from all...
Anglais

China, EU Respondents Optimistic About Prospects of Future Cooperation: GT Survey

Submitted by Anonyme on 2026-07-13T21:16:08+02:00
China and the EU have had established diplomatic relations for more than half a century. From the establishment of formal diplomatic relations to the development into a comprehensive strategic partnership, China-EU relations have become one of the most influential bilateral relationships in the world today. Apart from China, from October 16 to November 4, 2025, the Global Times Institute (GTI) conducted a questionnaire survey across 20 EU member states, including Denmark, Sweden, Spain, Belgium, and Germany, using 21 languages such as Spanish, French, German, and Chinese. More than 16,300 valid questionnaires were collected. The survey data shows that a majority of people in both China and EU are interested in each other's cultures, have...
Anglais
Subscribe to